Advertisement
UK markets close in 7 hours 15 minutes
  • FTSE 100

    8,282.95
    +69.46 (+0.85%)
     
  • FTSE 250

    20,354.52
    +189.98 (+0.94%)
     
  • AIM

    776.52
    +4.99 (+0.65%)
     
  • GBP/EUR

    1.1651
    -0.0009 (-0.08%)
     
  • GBP/USD

    1.2534
    -0.0030 (-0.24%)
     
  • Bitcoin GBP

    50,883.14
    -599.05 (-1.16%)
     
  • CMC Crypto 200

    1,369.42
    +4.30 (+0.31%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.58
    +0.10 (+0.13%)
     
  • GOLD FUTURES

    2,327.40
    -3.80 (-0.16%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,467.17
    -111.13 (-0.60%)
     
  • DAX

    18,228.56
    +53.35 (+0.29%)
     
  • CAC 40

    8,014.03
    +17.39 (+0.22%)
     

GlaxoSmithKline’s Valuation on June 29

GlaxoSmithKline’s Valuation on June 29

GlaxoSmithKline (GSK) is a global pharmaceutical company with a focus on sustainable growth through strategizing its business beyond pharmaceuticals. GlaxoSmithKline reports its financial statements in British pounds.